REMICADE (infliximab) and Crohn's - Accent 2 Study
Links shared publicly online about this topic.
- 1,216total visits
REMICADE (infliximab) and Crohn's - Accent 2 Study
View full resource at remicade.com
Tags: IBD, Crohn's Disease, Crohn's Disease Medication, Ulcerative Colitis Medication, Rheumatoid Arthritis Medication, Disease and Condition, Clinical Trial, Remicade
Most Recently Shared on April 25, 2010 at 3:16 am By:
Approval for Remicade maintenance therapy in fistulizing Crohn’s disease was based on results of the ACCENT II study. http://bit.ly/c5C05g
Remicade: first biological agent for paediatric ulcerative colitis | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on May 2, 2012 at 8:57 am By:
Remicade (infliximab): first biological agent licensed for paediatric ulcerative colitis: http://t.co/J4o7OTzh #gastroenterology
Understanding Crohn’s Disease | CD | REMICADE®
remicade.com — “Review the basic facts about Crohn’s disease, including causes, symptoms, and diagnosis.” View full resource at remicade.com
Most Recently Shared on March 23, 2012 at 12:17 pm By:
EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC
news-medical.net — “MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.” View full resource at news-medical.net
Most Recently Shared on January 21, 2012 at 9:30 am By:
Arthritis News: EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC: MSD today anno... http://t.co/qMuhwKHJ
Comments of using Remicade (study 4018339) - eHealthMe.com
ehealthme.com — “Couldn't walk after second Remicade infusion for Crohn's. Was switched to Humira with same results. Am now bedridden and can no longer work outside the home. Mayo Clinic diagnosed it as drug-induced lupus but blood markers are changing while symptoms are not.” View full resource at ehealthme.com
Most Recently Shared on December 12, 2011 at 10:11 am By:
Couldn't walk after second Remicade infusion for Crohn's. Was switched to Humira with same results. Am now be http://t.co/tbkKPdxZ
Medical News: ACG: No Cancer Risk With Biologic in Crohn's - in Meeting Coverage, ACG from MedPage Today
medpagetoday.com — “WASHINGTON -- Patients with Crohn's disease who are taking infliximab don't have a higher cancer rate than those on other therapies, a researcher said here.” View full resource at medpagetoday.com
Most Recently Shared on November 2, 2011 at 5:08 pm By:
ACG: No Cancer Risk With Biologic in Crohn's (CME/CE): WASHINGTON (MedPage Today) -- Patients… http://t.co/VoW7YhEh
How Remicade Infusion Pow-Wows Are Empowering PatientsHealth 2.0 News
health2news.com — “Sean Ahrens is one of Health 2.0's fastest rising stars. At the age of 12, he was diagnosed with Crohn's Disease, an incurable, inflammatory disease of the” View full resource at health2news.com
Most Recently Shared on October 12, 2011 at 10:03 pm By:
Health2.0 Conference Health Social Media
How Remicade Infusion Pow-Wows Are Empowering Patients by Sean Ahrens founder of http://t.co/dFrEuHwH @seanahrens @crohnology
Gastroenterology Article | Switch to adalimumab in patients with Crohns disease controlled by maintenance infliximab: prospective randomised SWITCH trial
mdlinx.com — “Switch to adalimumab in patients with Crohns disease controlled by maintenance infliximab: prospective randomised SWITCH trial” View full resource at mdlinx.com
Most Recently Shared on October 10, 2011 at 11:28 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Switch to adalimumab in patients with Crohns disease controlled by maintenance infliximab: prospective rando... http://t.co/AZ3F6oEe #GI
FDA approves Remicade to treat ulcerative colitis in children - News
virtualmedicalcentre.com — “The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children 6 years and older who have had inadequate response to conventional therapy.” View full resource at virtualmedicalcentre.com
Most Recently Shared on October 9, 2011 at 2:07 pm By:
VirtualMedicalCentre Health Site
FDA approves Remicade to treat ulcerative colitis in children http://t.co/oERwrjn9 #Healthnews
Crohn's Disease Support Network - CDSN
crohnsdiseasesn.com — “Spreading Crohn's Disease awareness because relating to each other, and knowing you are not alone is often the best medicine!” View full resource at crohnsdiseasesn.com
Most Recently Shared on September 27, 2011 at 10:54 am By:
Just added a new discussion on Crohn's Disease Support Network - CDSN "Remicade gets 16th approval" http://t.co/QAzRJoty
REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative Colitis
medicalnewstoday.com — “Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2011 at 8:05 am By:
Crohn Disease Wisdom OW Health
REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative Colitis: Janssen Biotech, ... http://t.co/maXFag05
Tumor Necrosis Factor-alpha (TNF?) Blockers: Label Change - Boxed Warning Updated for Risk of Infection from Legionella and Listeria - Drugs.com MedNews
drugs.com — “including Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), and Simponi (golimumab) AUDIENCE Rheumatology, Gastroent” View full resource at drugs.com
Most Recently Shared on September 8, 2011 at 2:14 pm By:
Drugs and Devices OW OW Health
Tumor Necrosis Factor-alpha (TNF?) Blockers: Label Change - Boxed Warning Updated for Risk of Infection fr... http://t.co/ywMmIfA #drug
Gastroenterology Article | Crohn Disease
mdlinx.com — “Infliximab and surgical treatment of complex anal Crohns disease” View full resource at mdlinx.com
Most Recently Shared on September 8, 2011 at 11:27 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Infliximab and surgical treatment of complex anal Crohns disease: Colorectal Disease http://t.co/nlGqbzg #GI
FDA Panel Backs Remicade for Kids With Ulcerative Colitis - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children.” View full resource at qualitypointtech.net
Most Recently Shared on July 21, 2011 at 10:45 pm By:
FDA Panel Backs Remicade for Kids With Ulcerative Colitis: (MedPage Today) -- SILVER SPRING, Md. -- An FDA advisor... http://bit.ly/na9znL
Medical News: FDA Panel Backs Remicade for Kids With Ulcerative Colitis - in Gastroenterology, Inflammatory Bowel Disease from MedPage Today
medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory panel has recommended expanding the indication for infliximab (Remicade) to include treatment of ulcerative colitis in children.” View full resource at medpagetoday.com
Most Recently Shared on July 21, 2011 at 10:16 pm By:
FDA Panel Backs Remicade for Kids With Ulcerative Colitis http://bit.ly/q09fHV
FDA Panel To Consider Additional Use For Remicade In Pediatric Patients
nasdaq.com — “NASDAQ News: FDA Panel To Consider Additional Use For Remicade In Pediatric Patients” View full resource at nasdaq.com
Most Recently Shared on July 20, 2011 at 12:59 pm By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
FDA Advisory Panel To Consider Expanding Infliximab For Use In Pediatric Patients: http://t.co/1N5PTXc
Advertisement
